Structured Summary
Abstract
Peptide Elongation Factor 2 catalyzes the translocation of peptidyl-tRNA from the A site to the P site of eukaryotic ribosomes by a process linked to the hydrolysis of GTP to GDP.
MeSH Record
Classification
Broader headings
Related Concepts
Knowledge Graph
Drag nodes to rearrange; hover to trace links; click a node to open its page.
MeSH Record
Synonyms
6 entry terms
- Cytoplasmic Elongation Factor 2
- EF-2
- Elongation Factor 2
- NSP 100
- NSP100
- EF 2
MeSH Record
Aspects Covered
30 allowable subheadings
Indexed with the subheadings administration & dosage, adverse effects, agonists, analysis, antagonists & inhibitors, biosynthesis, blood, cerebrospinal fluid, chemical synthesis, chemistry, classification, deficiency, drug effects, economics, genetics, history, immunology, isolation & purification, metabolism, pharmacokinetics, pharmacology, physiology, poisoning, radiation effects, standards, supply & distribution, therapeutic use, toxicity, ultrastructure, urine.
MeSH Record
History Note
2000; for ELONGATION FACTOR 2 use PEPTIDE ELONGATION FACTOR 2 (NM) 1980-1999
MeSH Record
Previous Indexing
- Peptide Elongation Factors (1980-1999)
MeSH Hierarchy
Tree Numbers
AMA Style
References
- National Library of Medicine. Peptide Elongation Factor 2. Medical Subject Headings (MeSH). 2026. Unique ID D020652. http://id.nlm.nih.gov/mesh/2026/D020652
- Peptide Elongation Factor 2. In: Wikipedia. https://en.wikipedia.org/wiki/EF-G
- Peptide Elongation Factor 2. In: Wikidata. https://www.wikidata.org/wiki/Q24778470